Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BNR will decline by -10.81% over the next 2 Weeks and hit $7.79 by Monday, June 15, 2026. In that time frame, BNR's share price is expected to range between $5.61 and $10.26.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 15, 2026 | 5.61 | 7.79 | 10.26 |
| Jun 12, 2026 | 5.11 | 7.34 | 9.66 |
| Jun 11, 2026 | 5.25 | 7.73 | 10.06 |
| Jun 10, 2026 | 5.02 | 7.32 | 9.63 |
| Jun 9, 2026 | 6.05 | 8.29 | 11.01 |
| Jun 8, 2026 | 6.32 | 8.51 | 10.77 |
| Jun 5, 2026 | 5.80 | 8.07 | 10.52 |
| Jun 4, 2026 | 6.02 | 8.46 | 10.92 |
| Jun 3, 2026 | 5.67 | 8.05 | 10.38 |
| Jun 2, 2026 | 6.71 | 9.02 | 11.35 |
BNR shares rose +12.71% in Tuesday, June 2, 2026's trading session, rising from a previous close of $8.73 to move at $9.84. The stock demonstrated notable intraday movement (see BNR's key stats for a full breakdown), fluctuating between $8.40 and $10.25, a +22.02% trading range. While recent weeks have seen some volatility, BNR has managed to secure a -41.08% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 45.56K shares changing hands, 9.14K more than the previous session. This amounted to $448.35K in total market activity.
Will BNR Continue Its Upward Trend?
According to analyst ratings and projections for BNR, Burning Rock Biotech Limited shares are anticipated to increase by +4.09%, potentially reaching $10.26 per share by June 15, 2026. Short-term technical indicators currently suggest a neutral sentiment for BNR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 8 positive trading days within the past 30 sessions. Based on the BNR stock forecast, now is a good time to buy BNR stock because its current trading price is +26.37% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BNR covering social and institutional perspectives.
BNR Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BNR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 25.19% to 31.54%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 41.50%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.34%, maintains a neutral outlook for the long term. Insights into BNR's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Burning Rock Biotech Short-Term Forecasts
BNR Forecast For Next 5 Days
Our algorithm anticipates Burning Rock Biotech (BNR) stock could hit $9.06 by Jun 09, 2026. This represents a -7.89% rise from today's price, following a +30.17% change over the past five days.
BNR Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Burning Rock Biotech Limited (BNR) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $7.95, which would mean a -19.21% decrease from the current price of $9.84. Projections for this period range from a high of $12.41 to a low of $3.28.
BNR Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Burning Rock Biotech's price over the next three months point to a rise. BNR stock is expected to peak at $19.21 on Jul 20, 2026 after potentially dipping to $12.20 on Jun 05, 2026. On average, BNR is likely to trade around $15.59 in the coming 90 days.
Burning Rock Biotech Stock Forecast 2025
Based on our predictive models, Burning Rock Biotech (BNR) is expected to trade between $6.89 and $35.11 throughout 2026. This would result in an average price of $16.35, potentially offering investors a +66.16% return from current levels.
Burning Rock Biotech Limited Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, Burning Rock Biotech Limited (BNR) is positioned to show a strong performance in June 2026. The price is predicted to move between $12.20 and $17.68, settling at an average of $14.85. This could translate to a +50.91% gain.
July 2026
Based on current market signals, Burning Rock Biotech Limited is projected to trend july 2026. We forecast a trading range from $15.02 to $19.21, with a likely average price of $17.35. Investors could expect a potential return of +76.32%.
August 2026
Our predictive algorithms indicate Burning Rock Biotech Limited stock may see a shift in August 2026. The expected range spans $13.22–$15.86, with an average target of $14.51. This represents a positive outlook and a possible gain of +47.46%.
September 2026
Analyzing established trends, Burning Rock Biotech Limited looks set to move in September 2026. Projections place the stock between $8.90 and $15.18, averaging around $12.42. This suggests a +26.22% gain from current levels.
October 2026
Market indicators suggest Burning Rock Biotech Limited could experience notable changes during October 2026. Prices could fluctuate within $6.89 to $11.34, with a midpoint forecast of $9.45. The stock might deliver a -3.96% loss.
November 2026
Forecasting for November 2026, models estimate that Burning Rock Biotech Limited may undergo key fluctuations. If trends hold, the stock might trade between $9.50 and $27.45, averaging $17.06. This signals a positive trajectory with potential returns around +73.37%.
December 2026
According to our latest forecast models, Burning Rock Biotech Limited (BNR) is positioned to show a strong performance in December 2026. The price is predicted to move between $22.48 and $35.11, settling at an average of $28.08. This could translate to a +185.37% gain.
January 2027
Based on current market signals, Burning Rock Biotech Limited is projected to trend january 2027. We forecast a trading range from $26.12 to $66.28, with a likely average price of $45.57. Investors could expect a potential return of +363.11%.
February 2027
Our predictive algorithms indicate Burning Rock Biotech Limited stock may see a shift in February 2027. The expected range spans $30.79–$66.11, with an average target of $48.84. This represents a positive outlook and a possible gain of +396.34%.
March 2027
Analyzing established trends, Burning Rock Biotech Limited looks set to move in March 2027. Projections place the stock between $14.43 and $45.48, averaging around $26.10. This suggests a +165.24% gain from current levels.
April 2027
Market indicators suggest Burning Rock Biotech Limited could experience notable changes during April 2027. Prices could fluctuate within $14.49 to $34.13, with a midpoint forecast of $23.43. The stock might deliver a +138.11% gain.
May 2027
Forecasting for May 2027, models estimate that Burning Rock Biotech Limited may undergo key fluctuations. If trends hold, the stock might trade between $11.25 and $31.96, averaging $21.07. This signals a positive trajectory with potential returns around +114.13%.
June 2027
According to our latest forecast models, Burning Rock Biotech Limited (BNR) is positioned to show a strong performance in June 2027. The price is predicted to move between $11.32 and $24.22, settling at an average of $17.48. This could translate to a +77.64% gain.
BNR's history of dividends and stock splits also plays a role in long-term investor confidence.

